Renaissance Technologies - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 33 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 1.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2019$913,000
-55.0%
4,450,473
+2.9%
0.00%
-50.0%
Q2 2019$2,029,000
+14.8%
4,326,528
+7.7%
0.00%0.0%
Q1 2019$1,768,000
+53.5%
4,017,705
+8.5%
0.00%
+100.0%
Q4 2018$1,152,000
-51.5%
3,702,967
+13.4%
0.00%
-50.0%
Q3 2018$2,374,000
+0.1%
3,266,401
-33.7%
0.00%
+100.0%
Q2 2018$2,371,000
+90.1%
4,924,200
+113.2%
0.00%0.0%
Q1 2018$1,247,000
-5.4%
2,309,500
+15.9%
0.00%0.0%
Q4 2017$1,318,000
+8.1%
1,993,500
-5.1%
0.00%0.0%
Q3 2017$1,219,000
-36.7%
2,101,300
-8.7%
0.00%
-50.0%
Q2 2017$1,927,000
-26.5%
2,300,800
+19.4%
0.00%
-50.0%
Q1 2017$2,621,000
+1130.5%
1,927,500
+302.1%
0.00%
Q4 2016$213,000
+106.8%
479,300
+165.0%
0.00%
Q3 2016$103,000
+56.1%
180,900
+75.8%
0.00%
Q2 2016$66,000
+43.5%
102,900
+87.4%
0.00%
Q1 2016$46,000
+119.0%
54,900
+162.3%
0.00%
Q4 2015$21,00020,9330.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Camber Capital Management LP 13,275,000$13,541,0000.88%
Broadfin Capital, LLC 3,338,570$3,405,0000.21%
Spark Investment Management LLC 229,600$234,0000.03%
Baillie Gifford 6,406,099$6,534,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 349,546$357,0000.01%
A.R.T. Advisors, LLC 80,108$81,0000.00%
Psagot Value Holdings Ltd. 101,876$103,0000.00%
WEDBUSH SECURITIES INC 18,000$18,0000.00%
TFS CAPITAL LLC 31,234$32,0000.00%
VAN ECK ASSOCIATES CORP 106,208$108,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders